DeutschNewstral
Article
Iinvezz.com on 2023-12-23 22:10
Bristol-Myers buying Karuna signals a biotech boom ahead: Jefferies
Related news
- MBristol Myers Squibb to purchase Karuna Therapeuticsmvtelegraph.com
Bristol Myers to Acquire the Drugmaker Karuna for $14 BillionThe New York Times- DKaruna Therapeutics soars after $14 billion takeover by Bristol Myersdcourier.com
- FBristol-Myers signs record biotech partnership dealft.com
Bristol Myers Squibb acquires Karuna Therapeutics for $14 billion, boosting neuroscience portfolioSeattle Times- IJefferies analyst reveals his top two biotech stocks for 2023invezz.com
- IExpert opinion: ‘Bristol-Myers is a buy’invezz.com
What’s Next For Bristol Myers Squibb Stock?Forbes
Behind Bristol-Myers' $600M acquisition of an Atlas biotech startupbizjournals.com- LMassBio Recognizes Eascra Biotech, Vertex Pharmaceuticals and Bristol Myers Squibblionessmagazine.com
Bristol Myers Stock Puts in a Tradable Bottomprofitconfidential.com- What To Expect From Bristol-Myers Squibb In Q1?Forbes
- IBristol-Myers Squibb stock forecast after announcing $15 billion buybackinvezz.com
- MCytomX's stock rockets after expanding Bristol-Myers collaborationmarketwatch.com
- Will Bristol Myers Squibb Stock Rise Post Q1?Forbes
- MCelgene's bonds rally sharply on news of Bristol-Myers takeovermarketwatch.com
- What’s Driving Growth For Bristol Myers Squibb Stock?Forbes
- MBristol-Myers and Nektar Therapeutics to jointly develop cancer treatmentsmarketwatch.com
Carl Icahn takes stake in Bristol Myers: WSJmetro.us